Form 4 · Filed May 27, 2026, 08:01 PM UTC
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo — Chief Operating Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 26, 2026 | M | other | 4,000 | $1 | $3,000 | 704,000 |
| May 26, 2026 | S | sell | 4,000 | $6 | $24,400 | 700,000 |
| May 26, 2026 | M | other | 4,000 | — | — | 897,395 |
| May 22, 2026 | M | other | 3,500 | $1 | $2,625 | 703,500 |
| May 22, 2026 | S | sell | 3,500 | $6 | $21,280 | 700,000 |
| May 22, 2026 | M | other | 3,500 | — | — | 901,395 |
Source: SEC EDGAR raw filing ↗ · Accession 0001140361-26-022980